Business Context and Reporting Period
This Form 8-K is filed by AmerisourceBergen Corporation (now Cencora, Inc.) on October 30, 2008. The report announces financial results for the fiscal quarter and full year ended September 30, 2008, and provides guidance for fiscal year 2009.
Key Financial Metrics
- Fiscal Year 2008 Diluted EPS: $2.89 from continuing operations.
- Fiscal Year 2009 Free Cash Flow Guidance: $460 million to $535 million.
- Fiscal Year 2009 Capital Expenditures: Approximately $140 million.
- Share Repurchase Program: Approximately $350 million planned for fiscal year 2009, subject to Board approval and market conditions.
Material Changes and Events
- Divestiture: Completed the sale of its PMSI workers' compensation business to H.I.G. Capital, LLC on October 29, 2008. This business is classified as a discontinued operation.
- Revenue Impact: The company noted a 3 percent negative impact on revenue growth due to the loss of a large retail drug chain effective July 1, 2008.
Guidance, Outlook, and Management Commentary
Management provided the following outlook for fiscal year 2009:
- Earnings Per Share: Diluted EPS is expected to range from $3.08 to $3.25, representing a 7% to 12% increase over fiscal 2008.
- Revenue Growth: Total revenue growth is projected between 1% and 3%, reflecting market conditions and customer mix.
- Operating Margin: Expansion is expected in the low to mid single-digit basis point range.
Investor Verification Checklist
- Verify the final closing details and financial impact of the PMSI workers' compensation business sale.
- Confirm the specific identity of the "large retail drug chain" lost in July 2008 and its long-term impact on the customer mix.
- Monitor the execution of the $350 million share repurchase program against actual market conditions.
- Review the full news release (Exhibit 99.1) for detailed segment performance data not included in this summary.